ISPC vs ROL · rev $9.3M vs P/E 41, rev $3.39B
iSpecimen Inc (ISPC) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
Latest reported ROL revenue for 2024-12-31 was $3.39B. Net income was $466.4M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
ISPC currently screens at market cap $4.4M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the ISPC and ROL stock pages for the full models.
Not investment advice.